商品名
通用名
中文名称
治疗领域
上市许可持有人
市场状态
ATC代码
批准日期
孤儿药
buprenorphine
丁丙诺啡
Opioid-Related Disorders
Neuraxpharm Pharmaceuticals S.L.
Authorised
N07BC01
2024-12-19
No
ustekinumab
乌司奴单抗
Crohn Disease;Colitis, Ulcerative
Accord Healthcare S.L.U.
Authorised
L04AC05
2024-12-12
No
ustekinumab
乌司奴单抗
Crohn Disease;Psoriasis;Arthritis, Psoriatic
Accord Healthcare S.L.U.
Authorised
L04AC05
2024-12-12
No
lutetium (177Lu) chloride
氯化镥[177Lu]
Radionuclide Imaging
Eckert & Ziegler Radiopharma GmbH
Authorised
V10X
2024-11-22
No
marstacimab
马塔西单抗
Hemophilia A;Hemophilia B
Pfizer Europe MA EEIG
Authorised
B02BX11
2024-11-18
No
influenza vaccine (surface antigen, inactivated, adjuvanted)
Influenza, Human
Seqirus Netherlands B.V.
Authorised
J07BB02
2024-11-15
No
influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
流感疫苗
Influenza, Human
Seqirus Netherlands B.V.
Authorised
J07BB02
2024-11-15
No
Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed)
ABCWY群脑膜炎球菌疫苗
Meningitis, Meningococcal
Pfizer Europe MA EEIG
Authorised
J07AH11
2024-11-14
No
mirvetuximab soravtansine
索米妥昔单抗
Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms
AbbVie Deutschland GmbH & Co. KG
Authorised
L01FX26
2024-11-14
Yes
aflibercept
阿柏西普
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion
Samsung Bioepis NL B.V.
Authorised
S01LA05
2024-11-13
No
aflibercept
阿柏西普
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion
Sandoz GmbH
Authorised
S01LA05
2024-11-13
No
macitentan;tadalafil
马昔腾坦；他达拉非
Pulmonary Arterial Hypertension
Janssen-Cilag International NV
Authorised
C02KX54
2024-09-27
No
ustekinumab
乌司奴单抗
Crohn Disease;Colitis, Ulcerative;Psoriasis;Arthritis, Psoriatic
Formycon AG
Authorised
L04AC05
2024-09-25
No
ustekinumab
乌司奴单抗
Crohn Disease;Colitis, Ulcerative
Fresenius Kabi Deutschland GmbH
Authorised
L04AC05
2024-09-25
No
axitinib
阿昔替尼
Carcinoma, Renal Cell
Accord Healthcare S.L.U.
Authorised
L01EK01
2024-09-19
No